Discussion of the new standards of care for diabetes for 2024. This session will focus on updates in diabetes care and management. We will highlight new drugs to market and delve into navigating the ongoing shortages of GLP1 medications. Updates will be provided on continuous glucose monitor technology, including the newly approved Stelo Glucose Biosensor system by Dexcom, available OTC, without a prescription. Insulin pumps and automated insulin delivery system advances will also be presented. There will be ample time for open discussion and questions and answers.